Alejandro Navarro
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
Papers in
- Oncology 77
- Lung Cancer Research Studies 56
- Peptidase Inhibition and Analysis 18
- Cancer Immunotherapy and Biomarkers 13
-
- Lung Cancer Treatments and Mutations 29
- Occupational and environmental lung diseases 8
- Co-authors
- Enriqueta Felip (43 shared papers)S. Cedrés (33 shared papers)Alex Martínez‐Martí (24 shared papers)Pablo Martínez (8 shared papers)Melissa L. Johnson (4 shared papers)Alice T. Shaw (3 shared papers)Antonello Abbattista (3 shared papers)Justin F. Gainor (3 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Annals of Oncology (21 papers)Journal of Thoracic Oncology (17 papers)Lung Cancer (5 papers)Clinical & Translational Oncology (3 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Alejandro Navarro
107 papers receiving 2.7k citations
Alejandro Navarro's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 210
- Immunology 252
- Epidemiology 372
Countries citing papers authored by Alejandro Navarro
This map shows the geographic impact of Alejandro Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Navarro more than expected).
Fields of papers citing papers by Alejandro Navarro
This network shows the impact of papers produced by Alejandro Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Navarro. The network helps show where Alejandro Navarro may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Navarro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study Hit paper breakdown → | 2020 | 508 |
| 2 | Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial Hit paper breakdown → | 2017 | 490 |
| 3 | 2017 | 283 | |
| 4 | 2012 | 225 | |
| 5 | 2015 | 146 | |
| 6 | 2020 | 81 | |
| 7 | 2019 | 66 | |
| 8 | 2022 | 60 | |
| 9 | 2022 | 56 | |
| 10 | 2017 | 55 | |
| 11 | 2016 | 31 | |
| 12 | 2021 | 30 | |
| 13 | 2024 | 29 | |
| 14 | 2020 | 29 | |
| 15 | 2018 | 29 | |
| 16 | 2020 | 27 | |
| 17 | 2017 | 25 | |
| 18 | 2019 | 22 | |
| 19 | 2023 | 21 | |
| 20 | 2014 | 18 |
About Alejandro Navarro
Alejandro Navarro is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Cancer Research, having authored 111 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (56 papers), Lung Cancer Treatments and Mutations (29 papers), Cancer therapeutics and mechanisms (24 papers), Peptidase Inhibition and Analysis (18 papers), Cancer Immunotherapy and Biomarkers (13 papers), Neuroendocrine Tumor Research Advances (10 papers), Fibroblast Growth Factor Research (8 papers) and Occupational and environmental lung diseases (8 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (210 citations), Immunology (252 citations) and Epidemiology (372 citations). Alejandro Navarro has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Enriqueta Felip, S. Cedrés, Alex Martínez‐Martí, Pablo Martínez, Melissa L. Johnson, Alice T. Shaw, Antonello Abbattista, Justin F. Gainor, Todd M. Bauer and Benjamin Besse. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.